Updated:
Flying L Partners
At Flying L Partners, we team with high-performance companies to bring capital and knowhow to accelerate innovation and value creation. With a focus primarily...
Flying L Partners
At Flying L Partners, we team with high-performance companies to bring capital and knowhow to accelerate innovation and value creation. With a focus primarily on the ophthalmic space, the principals in Flying L Partners have been involved in building, leading, and funding high impact technologies for over 30 years. Our mission is to create value for investors by bringing meaningful innovation to providers and patients to improve vision and treat diseases. We adhere to the principle that if it is better medicine and better business, then value will be created. When we do well, many people will benefit.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
North America
Country
United States
City
Newport Beach
Corporate office
Newport Beach, CA, United States
Principals
William Link
Managing Partner
Andy Corley
Partner
Richard Lindstrom
Partner
Matthew Larson
Administrative Partner
Jeevan Gore
Chief Operating Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Flying L Partners?
Managing Partner William Link, alongside Partners Andy Corley and Richard Lindstrom, leads investment decisions. Link is a managing director of Versant Ventures and a serial founder of ophthalmology device companies; Corley previously co-founded and sold eyeonics; Lindstrom is a practicing surgeon at Minnesota Eye Consultants. The trio bring a mix of venture, operational, and clinical expertise to deal evaluation.
Is Flying L Partners structured as a traditional venture fund?
No, the firm raises capital on a per-transaction basis. Once it identifies a single promising ophthalmic company, it forms a capital-raising effort dedicated to that asset. The model avoids a blind-pool fund structure, giving co-investors line-by-line exposure and allowing the firm to size each round to the specific clinical or regulatory milestone.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: